This study developed composite hydrogel scaffolds from chitosan (CS), silk fibroin (SF), and Aloe vera (AV) gel extract for cartilage tissue engineering. SF extracted from Nang-Laai silkworm cocoons showed high protein content (86.8%), while AV extract contained characteristic polysaccharides. Scaffolds with varying CS/SF/AV ratios were fabricated and evaluated for physicochemical and biological properties. Among all formulations, CS40/SF/AV (3.00%wt CS, 2.70%wt SF, 0.075%wt AV) exhibited superior porosity (72.23 ± 4.85%), pore size (79.57 ± 3.68 μm), and compressive strength, both in dry (6.67 ± 1.44 MPa) and wet states. It also showed controlled swelling (270%) and a stable degradation profile (55–57% over 21 days). FTIR and XRD confirmed successful component integration and semi-crystalline structure. In vitro, CS40/SF/AV supported chondrocyte adhesion, proliferation, and morphology retention over 28 days. Fluorescence imaging showed uniform cell distribution across the scaffold. These results highlight the CS40/SF/AV scaffold as a promising, biocompatible platform with optimal mechanical and structural properties for cartilage regeneration, offering potential for further in vivo applications.

Diabetic wounds remain a major clinical challenge due to delayed healing caused by chronic inflammation and impaired fibroblast activity. Here, we present a thermoresponsive gel composed of chitosan (CS) and poloxamers (POL) incorporating silk fibroin (SFB) and Aloe vera gel extract (AV), developed for topical application and, for the first time, evaluated using an inflammation-induced diabetic fibroblast model. The optimized formulation exhibited rapid sol–gel transition at physiological temperature and suitable rheological properties for effective wound coverage. In vitro evaluation using human normal fibroblasts (HNF) and human diabetic fibroblasts (HDF), under both basal and inflammation-induced conditions, demonstrated good cytocompatibility and a significant enhancement of fibroblast migration, particularly in an inflammatory microenvironment simulated by high glucose, lipopolysaccharide (LPS), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α). These findings highlight the potential of the developed thermoresponsive gel as a promising biomaterial platform for improving diabetic wound healing under inflammation-relevant conditions.

Chronic and diabetic wounds are characterized by persistent inflammation, excessive oxidative stress, and impaired cellular responses, collectively leading to delayed tissue repair. This study aimed to evaluate a thermoresponsive gel incorporating Aloe vera (AV) extracts and silk fibroin (SF), focusing on its biocompatibility, anti-inflammatory, antioxidant, and pro-regenerative potential. The AV: SF mixture and gel formulation were evaluated in macrophage-like THP-1 cells, and human diabetic dermal fibroblasts (HDdF) under non-induced and LPS/IL-6/TNF-α-induced inflammatory conditions. Both formulations maintained high cell viability across all cell types, indicating good biocompatibility. Under inflammatory conditions, both the AV: SF mixture and gel significantly reduced intracellular ROS levels and suppressed TNF-α and IL-1β secretion. In addition, NF-κB p65 activation was attenuated in both macrophage-like THP-1 cells and HDdF. Macrophage-like THP-1 cells displayed the M2 (CD80^low/CD206^high) phenotype, indicating modulation of macrophage polarization toward wound remodeling and repair. Overall, the AV: SF-based gel system demonstrated coordinated antioxidant, anti-inflammatory, and pro-regenerative effects in vitro. These findings support its potential as a multifunctional biomaterial for modulating inflammation-associated cellular dysfunction in chronic and diabetic wound environments.